Seminars in Arthritis and Rheumatism

Article	Citations
Gout epidemiology and comorbidities	164
Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease	115
Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs	114
The Jak/STAT pathway: A focus on pain in rheumatoid arthritis	96
C-reactive protein and implications in rheumatoid arthritis and associated comorbidities	96
The biology of urate	84
The Prevalence of Psychiatric and Chronic Pain Comorbidities in Fibromyalgia: an ACTTION systematic review	82
Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review	82
Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies	76
Understanding differences between men and women with axial spondyloarthritis	65
Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United States	59
Prevalence of interstitial lung disease in polymyositis and dermatomyositis: A meta-analysis from 2000 to 2020	58
Therapeutic approaches in the treatment of gout	57
COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients	50
Axial involvement in psoriatic arthritis: An update for rheumatologists	49
Antisynthetase syndrome – much more than just a myopathy	48
What we already know about the effects of exercise in patients with fibromyalgia: An umbrella review	48
Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review	47
Addressing the rheumatology workforce shortage: A multifaceted approach	45
COVID-19 in rheumatic disease patients on immunosuppressive agents	45
Is there a bidirectional association between rheumatoid arthritis and periodontitis? A systematic review and meta-analysis	45
The cost savings of biosimilars can help increase patient access and lift the financial burden of health care systems	41
Fibromyalgia and obesity: A comprehensive systematic review and meta-analysis	40
Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand?	40
Visual and semiquantitative assessment of cranial artery inflammation with FDG-PET/CT in giant cell arteritis	40

Effectiveness of tocilizumab in Behcet's disease: A systematic literature review	39
The ASAS-OMERACT core domain set for axial spondyloarthritis	37
Sexual function and reproduction can be impaired in men with rheumatic diseases: A systematic review	37
Comparison of an online self-referral tool with a physician-based referral strategy for early recognition of patients with a high probability of axial spa	36
DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study	35
Advances in our understanding of gout as an auto-inflammatory disease	35
Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO regi	34
Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data	33
The role of PTPN22 in the pathogenesis of autoimmune diseases: A comprehensive review	33
Clinical characteristics and risk factors of infection in patients with systemic lupus erythematosus: A systematic review and meta-analysis of observational studies	32
Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis	31
Carotid plaques as predictors of cardiovascular events in patients with Rheumatoid Arthritis. Results from a 5-year-prospective follow-up study	31
The prevalence and risk factors of sarcopenia in rheumatoid arthritis patients: A systematic review and meta-regression analysis	31
The glucocorticoid toxicity index: Measuring change in glucocorticoid toxicity over time	31
Safety and effectiveness of abatacept in systemic sclerosis: The EUSTAR experience	31
Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis	30
Efficacy and safety of sirolimus in patients with systemic lupus erythematosus: A systematic review and meta-analysis	30
Relapses and long-term remission in large vessel giant cell arteritis in northern Italy: Characteristics and predictors in a long-term follow-up study	30
Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients	30
Maternal and perinatal outcomes of pregnancies in systemic lupus erythematosus: A nationwide population-based study	30
Methotrexate treatment in hand osteoarthritis refractory to usual treatments: A randomised, double-blind, placebo-controlled trial	29
Severe axial and pelvifemoral muscle damage in immune-mediated necrotizing myopathy evaluated by whole-body MRI	28
The economic burden of fibromyalgia: A systematic literature review	28
Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis	28
Effects of successive switches to different biosimilars infliximab on immunogenicity in chronic inflammatory diseases in daily clinical practice	28
The experience of a gout flare: a meta-synthesis of qualitative studies	28
Risk of malignancy with non-TNFi biologic or tofacitinib therapy in rheumatoid arthritis: A meta-analysis of observational studies	28
Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease	28
Beyond urate lowering: Analgesic and anti-inflammatory properties of allopurinol	27
Gut microbiota changes in patients with spondyloarthritis: A systematic review	27
TNF-alpha inhibition for the treatment of cardiac sarcoidosis	27
The effect of immunomodulators on the efficacy and tolerability of pegloticase: a systematic review	27
Management of calcium pyrophosphate crystal deposition disease: A systematic review	27
An increased disease burden of autoimmune inflammatory rheumatic diseases in Korea	26
The evolution of instrument selection for inclusion in core outcome sets at OMERACT: Filter 2.2	26
Epidemiology of depression and anxiety in patients with psoriatic arthritis: A systematic review and meta-analysis	26
Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis	26
Towards classification criteria for early-stage knee osteoarthritis: A population-based study to enrich for progressors	26
Pegloticase treatment of chronic refractory gout: Update on efficacy and safety	25
Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis	25
Patterns of clinical presentation in Takayasu's arteritis	25
The prevalence of gout and hyperuricaemia in Australia: An updated systematic review	25
Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study	25
Tocilizumab in isolated polymyalgia rheumatica: A systematic literature review	24
The effects of sprifermin on symptoms and structure in a subgroup at risk of progression in the FORWARD knee osteoarthritis trial	24
Mortality in psoriatic arthritis: Risk, causes of death, predictors for death	24
Outcome of refractory to conventional and/or biologic treatment adult Still's disease following canakinumab treatment: Countrywide data in 50 patients	24
Real-world clinical effectiveness of rituximab rescue therapy in patients with progressive rheumatoid arthritis-related interstitial lung disease	24
Vasculitis associated with myelodysplastic syndrome and chronic myelomonocytic leukemia: French multicenter case-control study	23
Cryoglobulinemia after the era of chronic hepatitis C infection	23

Abatacept in the treatment of localized scleroderma: A pediatric case series and systematic literature review	23
Tocilizumab vs placebo for the treatment of giant cell arteritis with polymyalgia rheumatica symptoms, cranial symptoms or both in a randomized trial	23
COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis	23
Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study	22
Long, relapsing, and atypical symptomatic course of COVID-19 in a B-cell-depleted patient after rituximab	22
Significance of inflammation restricted to adventitial/periadventitial tissue on temporal artery biopsy	22
Definition of B cell helper T cells in rheumatoid arthritis and their behavior during treatment	22
Telemedicine in rheumatology care: A systematic review	22
Risk of interstitial lung disease in patients with newly diagnosed systemic autoimmune rheumatic disease: A nationwide, population-based cohort study	22
Granulomatosis with polyangiitis: Study of 795 patients from the French Vasculitis Study Group registry	22
Immunopathogenesis of Behçet's disease and treatment modalities	21
Clinical osteoarthritis of the hip and knee and fall risk: The role of low physical functioning and pain medication	21
Incidence and clinical course of COVID-19 in patients with rheumatologic diseases: A population-based study	21
Consensus-based semi-quantitative ultrasound scoring system for gout lesions: Results of an OMERACT Delphi process and web-reliability exercise	21
The economic burden of systemic lupus erythematosus in commercially- and medicaid-insured populations in the United States	21
How the COVID-19 pandemic has influenced pediatric rheumatology practice: Results of a global, cross-sectional, online survey	21
Additive effect of leflunomide and glucocorticoids compared with glucocorticoids monotherapy in preventing relapse of IgG4-related disease: A randomized clinical trial	20
Overall and site-specific cancer before and after diagnosis of idiopathic inflammatory myopathies: A nationwide study 2002–2016	20
Patients with asthma have a higher risk of rheumatoid arthritis: A systematic review and meta-analysis	20
Risk of exacerbation of pulmonary comorbidities in patients with rheumatoid arthritis after initiation of abatacept versus TNF inhibitors: A cohort study	20
Pregnancy in axial spondyloarthropathy: A systematic review & meta-analysis	20
Efficacy of home-based physical activity interventions in patients with autoimmune rheumatic diseases: A systematic review and meta-analysis	20
Comparative effectiveness of exercise programs for psychological well-being in knee osteoarthritis: A systematic review and network meta-analysis	19
Rheumatoid arthritis and risk of lung cancer: Meta-analysis and Mendelian randomization study	19
From incomplete to complete systemic lupus erythematosus; A review of the predictive serological immune markers	19
Rheumatoid arthritis-related lung disease detected on clinical chest computed tomography imaging: Prevalence, risk factors, and impact on mortality	19
Improving domain definition and outcome instrument selection: Lessons learned for OMERACT from imaging	19
Methotrexate use reduces mortality risk in rheumatoid arthritis: A systematic review and meta-analysis of cohort studies	19
The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies	18
Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review	18
Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort	18
Biologic treatments in Takayasu's Arteritis: A comparative study of tumor necrosis factor inhibitors and tocilizumab	18
Incident diabetes associated with hydroxychloroquine, methotrexate, biologics and glucocorticoids in rheumatoid arthritis: A systematic review and meta-analysis	18
Utility of patient-reported outcomes measurement information system (PROMIS) physical function form in inflammatory myopathy	18
Central sensitization has major impact on quality of life in patients with axial spondyloarthritis	18
The patient global assessment in RA precludes the majority of patients otherwise in remission to reach this status in clinical practice. Should we continue to ignore this?	18
Use and reporting of outcome measures in randomized trials for anti-neutrophil cytoplasmic antibody-associated vasculitis: a systematic literature review	17
Physical modalities for the conservative treatment of wrist and hand's tenosynovitis: A systematic review	17
Epidemiology and mortality of connective tissue disease-associated pulmonary arterial hypertension: A national cohort study in taiwan	17
Efficacy and safety of immunomodulatory drugs in patients with non-infectious intermediate and posterior uveitis, panuveitis and macular edema: A systematic literature review	17
Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: A retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C)	17
Systemic sclerosis overlap and non-overlap syndromes share clinical characteristics but differ in prognosis and treatments	17
Clinical and biochemical factors associated with risk of total joint replacement and radiographic progression in osteoarthritis: Data from two phase III clinical trials	17
Prevalence and prognostic factors for aortic dilatation in giant cell arteritis – a longitudinal study	17
A seasonal pattern in the onset of polymyalgia rheumatica and giant cell arteritis? A systematic review and meta-analysis	17
Muscle pathological features and extra-muscle involvement in idiopathic inflammatory myopathies with anti-mitochondrial antibody	17
Rituximab as a rescue treatment added on mycophenolate mofetil background therapy in progressive systemic sclerosis associated interstitial lung disease unresponsive to conventional immunosuppression	17
Characteristics of pediatric Behçet's disease in Turkey and Israel: A cross-sectional cohort comparison	17
MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression	17
Validation of claims-based algorithms to identify interstitial lung disease in patients with rheumatoid arthritis	16
Treatment-resistant synovitis and radiographic progression are increased in elderly-onset rheumatoid arthritis patients: findings from a prospective observational longitudinal early arthritis cohort s	16
Axial Disease in Psoriatic arthritis: The presence and progression of unilateral grade 2 sacroiliitis in a psoriatic arthritis cohort	16
Incidence and progression of ankle osteoarthritis: The johnston county osteoarthritis project	16
Consensus-driven conceptual development of a standardized whole body-MRI scoring system for assessment of disease activity in juvenile idiopathic arthritis: MRI in JIA OMERACT working group	16
Association of silica exposure with chest HRCT and clinical characteristics in systemic sclerosis	16
Pain in women with knee and/or hip osteoarthritis is related to systemic inflammation and to adipose tissue dysfunction: Cross-sectional results of the KHOALA cohort	16
Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational study	16
Rheumatoid arthritis and inflammatory bowel disease: A bidirectional two-sample Mendelian randomization study	16
Shared decision making in rheumatology: A scoping review	15
The phenotype of myositis patients with anti-Ku autoantibodies	15
Antiphospholipid antibodies and lower extremity peripheral artery disease: A systematic review and meta-analysis	15
Pregnancy outcomes in patients treated with belimumab: Report from real-world experience	15
Conventional ultrasound and elastography as imaging outcome tools in autoimmune myositis: A systematic review by the OMERACT ultrasound group	15
Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study	15
RISE registry reveals potential gaps in medication safety for new users of biologics and targeted synthetic DMARDs	15
Identification and characterization of peripheral vascular color-coded DECT lesions in gout and non-gout patients: The VASCURATE study	15
Giant cell arteritis: A nationwide, population-based cohort study on incidence, diagnostic imaging, and glucocorticoid treatment	15
Unveiling axial involvement in psoriatic arthritis: An ancillary analysis of the ASAS-perSpA study	15
Understanding of cytokines and targeted therapy in macrophage activation syndrome	15
Unravelling the mysteries of gout by multimodality imaging	15
Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients	15
Childhood-onset versus adult-onset Takayasu arteritis: A study of 141 patients from Turkey	14
Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry	14
High-density lipoprotein functionality in systemic lupus erythematosus	14
Systematic review of childhood-onset polyarteritis nodosa and DADA2	14
Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate vs. alendronate monotherapy in women at increased risk of fracture: A US payer perspective	14
Pseudotumoral calcinosis in systemic sclerosis: Data from systematic literature review and case series from two referral centres	14
Association between central nervous system stimulants used to treat attention deficit hyperactivity disorder (ADHD) and Raynaud's phenomenon: A scoping review	14
DADA2 diagnosed in adulthood versus childhood: A comparative study on 306 patients including a systematic literature review and 12 French cases	14
Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: A systematic review	14

Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach	14
Evolution of high-resolution CT-scan in systemic sclerosis-associated interstitial lung disease: Description and prognosis factors	14
The patient's perspective of the adverse effects of glucocorticoid use: A systematic review of quantitative and qualitative studies. From an OMERACT working group	14
The clinical and serological associations of hypocomplementemia in a longitudinal sle cohort	14
The cancer risk according to three subtypes of ANCA-associated vasculitis: A propensity score-matched analysis of a nationwide study	14
Chronic inflammatory demyelinating polyradiculoneuropathy associated with systemic lupus erythematosus	14
Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip: A 16-week dose-titration study	14
Patterns and predictors of recurrent acute care use among Medicaid beneficiaries with systemic lupus erythematosus	14
Ultrasound and elastography in the assessment of skin involvement in systemic sclerosis: A systematic literature review focusing on validation and standardization – WSF Skin Ultrasound Group	14
OMERACT definition and reliability assessment of chronic ultrasound lesions of the axillary artery in giant cell arteritis	14
Concurrent baseline diagnosis of giant cell arteritis and polymyalgia rheumatica – A systematic review and meta-analysis	13
Disease and treatment-related morbidity in young and elderly patients with granulomatosis with polyangiitis and microscopic polyangiitis	13
Comorbidities in patients with polymyalgia rheumatica prior to and following diagnosis: A case control and cohort study	13
Effect of statin use on the risk of rheumatoid arthritis: A systematic review and meta-analysis	13
Predictors of infection requiring hospitalization in patients with systemic lupus erythematosus: a time-to-event analysis	13
Neurological manifestations of autoinflammatory diseases in Chinese adult patients	13
Childhood Sjogren's syndrome: An Italian case series and a literature review-based cohort	13
Symptom experience of limited cutaneous systemic sclerosis from the Patients’ perspective: A qualitative study✰,✰✰,★,★★	13
Drug retention rates of biological agents in adult onset Still's disease	13
Efficacy and safety of canakinumab treatment in schnitzler syndrome: A systematic literature review	13
Evaluation of the impact of a nurse-led program of systematic screening of comorbidities in patients with axial spondyloarthritis: The results of the COMEDSPA prospective, controlled, one year randomi	13
AA amyloidosis revealing mevalonate kinase deficiency: A report of 20 cases including two new French cases and a comprehensive review of literature	13
Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients	13
Interleukins and rheumatoid arthritis: bi-directional Mendelian randomization investigation	13
Pregnancy in women with psoriatic arthritis: A systematic literature review of disease activity and adverse pregnancy outcomes	13
Prevalence and risk factors of bronchiectasis in rheumatoid arthritis: A systematic review and meta-analysis	12
How is early spondyloarthritis defined in the literature? Results from a systematic review	12
The safety of pulse corticosteroid therapy- Systematic review and meta-analysis	12
The impact of a disease flare during tapering of DMARDs on the lives of rheumatoid arthritis patients	12
Does smoking protect against developing osteoarthritis? Evidence from a genetically informed perspective	12
Screening for the early detection of pulmonary arterial hypertension in patients with systemic sclerosis: A systematic review and meta-analysis of long-term outcomes	12
Severity and mortality of COVID-19 in patients with systemic sclerosis: a Brazilian multicenter study	12
Giant cell arteritis-related aortic dissection: A multicenter retrospective study	12
The Story Behind the Use of Glucocorticoids in the Treatment of Rheumatoid Arthritis	12
Endorsement of the domains of knee and hip osteoarthritis (OA) flare: A report from the OMERACT 2020 inaugural virtual consensus vote from the flares in OA working group	12
The incidence and risk factors for venous thromboembolic events in patients with psoriasis and psoriatic arthritis	12
Long-term abatacept treatment for 48 weeks in patients with primary Sjögren's syndrome: The open-label extension phase of the ASAP-III trial	12
Pregnancy issues in Takayasu arteritis	12
Validation of the Musculoskeletal Health Questionnaire (MSK-HQ) in primary care patients with musculoskeletal pain	12
Performance of laser-derived imaging for assessing digital perfusion in clinical trials of systemic sclerosis-related digital vasculopathy: A systematic literature review	12
Relationship between change in physical activity and in clinical status in patients with idiopathic inflammatory myopathy: A prospective cohort study	12
Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score	12
Does type 2 diabetes increase the risk of musculoskeletal pain? Cross-sectional and longitudinal analyses of UK biobank data	11
Are troponin and B-type natriuretic peptides useful biomarkers for the diagnosis of systemic sclerosis heart involvement? A systematic literature review	11
Occupation and risk of knee osteoarthritis and knee replacement: A longitudinal, multiple-cohort study	11
Efficacy and safety of tofacitinib versus leflunomide with glucocorticoids treatment in Takayasu arteritis: A prospective study	11
Unsupervised machine-learning algorithms for the identification of clinical phenotypes in the osteoarthritis initiative database	11
Longitudinal relationships between cognitive domains and depression and anxiety symptoms in systemic lupus erythematosus	11
Giant cell arteritis and its mimics: A comparison of three patient cohorts	11
Trends in incidence of dementia among patients with rheumatoid arthritis: A population-based cohort study	11
COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis	11
A systematic review of the infectious complications of colchicine and the use of colchicine to treat infections	11
Global patterns of treat-to-serum urate target care for gout: Systematic review and meta-analysis	11
Geographical variations in COVID-19 perceptions and patient management: a national survey of rheumatologists	11
How should we treat palindromic rheumatism? A systematic literature review	11
Racial and ethnic differences in medication use among beneficiaries of social security disability insurance with rheumatoid arthritis	11
Association of cardiovascular disease and traditional cardiovascular risk factors with the incidence of dementia among patients with rheumatoid arthritis	11
Incidence, sociodemographic factors and treatment penetration of rheumatoid arthritis and psoriatic arthritis in Norway	11
Assessment of damage in Takayasu‘s arteritis	11
Characteristics and risk factors for poor outcome in patients with systemic vasculitis involving the gastrointestinal tract	11
Metrics and definitions used in the assessment of cognitive impairment in systemic lupus erythematosus: A systematic review	11
Efficacy and safety of canakinumab in the treatment of adult-onset Still's disease: A systematic review	11
Developing a core set of outcome measure domains to study Raynaud's phenomenon and digital ulcers in systemic sclerosis: Report from OMERACT 2020	11